Global Biodegradable Drug Eluting Stents Market Insights - Industry Share, Sales Projections, and Demand Outlook 2026-2032

The global Biodegradable Drug Eluting Stents market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, witnessing a CAGR of %during the forecast period 2026-2032.

Biodegradable Polymer Drug-eluting Stents (BP-DES) are medical devices used in the treatment of coronary artery disease. Unlike traditional stents that use permanent polymer coatings to release drugs, BP-DES incorporate biodegradable polymers that gradually degrade over time, leaving behind only the bare metal stent. These stents are designed to release drugs, typically anti-proliferative or anti-inflammatory agents, to prevent restenosis (re-narrowing of the artery) after angioplasty. The biodegradable polymer technology reduces the risk of long-term complications associated with permanent polymer stents, such as inflammation and late stent thrombosis, while still providing effective drug delivery to inhibit cell growth and maintain vessel patency.

North American market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2025 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Biodegradable Drug Eluting Stents is estimated to increase from $ million in 2025 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Biodegradable Drug Eluting Stents include Boston Scientific, Biotronik, Biosensors International, TERUMO, MicroPort Scientific, Lepu Medical, JW Medical, SINOMED, Bio-heart, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biodegradable Drug Eluting Stents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biodegradable Drug Eluting Stents.

The Biodegradable Drug Eluting Stents market size, estimations, and forecasts are provided in terms of sales quantity (Units) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Biodegradable Drug Eluting Stents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biodegradable Drug Eluting Stents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Chapter Outline:

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: key insights, key emerging trends, etc.

Chapter 3: Manufacturers competitive analysis, detailed analysis of Biodegradable Drug Eluting Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 5 & 6: Sales, revenue of Biodegradable Drug Eluting Stents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: The main points and conclusions of the report.